Stonehage Fleming (UK)’s Johnson & Johnson JNJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2015
Q4
$638K Sell
6,212
-650
-9% -$65.4K 0.29% 98
2015
Q3
$640K Buy
6,862
+1,662
+32% +$161K 0.31% 97
2015
Q2
$507K Hold
5,200
0.23% 105
2015
Q1
$523K Hold
5,200
0.24% 102
2014
Q4
$131K Hold
5,200
0.06% 139
2014
Q3
$133K Hold
5,200
0.06% 159
2014
Q2
$544K Sell
5,200
-350
-6% -$35.4K 0.22% 100
2014
Q1
$545K Buy
5,550
+300
+6% +$27.8K 0.23% 100
2013
Q4
$481K Buy
+5,250
New +$484K 0.19% 103

Other funds holding JNJ

Stonehage Fleming (UK)'s JNJ Position: Q4 2015 in Review

Stonehage Fleming (UK) reduced its Johnson & Johnson (JNJ) stake by 9.5% in Q4 2015, selling an estimated $65.4K and leaving 6,212 shares worth $638K. The position accounts for 0.29% of the portfolio, ranked #98.

Stonehage Fleming (UK) first reported a position in JNJ in Q4 2013 and has held it in 9 quarters since. The position peaked at $640K in Q3 2015. 2,193 funds tracked by Wall St. Rank hold JNJ as of Q4 2015.

  • Stonehage Fleming (UK) held 6,212 shares of Johnson & Johnson worth $638K as of Q4 2015.
  • Stonehage Fleming (UK) sold 650 Johnson & Johnson shares in Q4 2015, an estimated $65.4K.
  • Johnson & Johnson made up 0.29% of Stonehage Fleming (UK)'s portfolio in Q4 2015, its #98 holding.
  • Stonehage Fleming (UK) first reported a position in Johnson & Johnson in Q4 2013 and has held it in 9 quarters since.
  • Stonehage Fleming (UK)'s Johnson & Johnson position peaked at $640K in Q3 2015.
  • 2,193 funds tracked by Wall St. Rank held Johnson & Johnson as of Q4 2015.

Based on Stonehage Fleming (UK)'s 13F filing for Q4 2015, filed 11 Oct 2019.